ABOS
Price
$4.10
Change
+$0.35 (+9.33%)
Updated
Mar 27, 6:59 PM EST
46 days until earnings call
MOR
Price
$18.14
Change
-$0.04 (-0.22%)
Updated
Mar 27, 6:59 PM EST
32 days until earnings call
Ad is loading...

Compare predictions ABOS vs MOR

Header iconABOS vs MOR Comparison
Open Charts ABOS vs MORBanner chart's image
Acumen Pharmaceuticals
Price$4.10
Change+$0.35 (+9.33%)
Volume$388.6K
CapitalizationN/A
MorphoSys AG
Price$18.14
Change-$0.04 (-0.22%)
Volume$149.46K
CapitalizationN/A
View a ticker or compare two or three
ABOS vs MOR Comparison Chart

Loading...

ABOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABOS vs. MOR commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Buy and MOR is a StrongSell.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ABOS: $4.10 vs. MOR: $18.14)
Brand notoriety: ABOS and MOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 158% vs. MOR: 12%
Market capitalization -- ABOS: $237.43M vs. MOR: $2.74B
ABOS [@Biotechnology] is valued at $237.43M. MOR’s [@Biotechnology] market capitalization is $2.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileMOR’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • MOR’s FA Score: 1 green, 4 red.
According to our system of comparison, MOR is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 6 TA indicator(s) are bullish while MOR’s TA Score has 2 bullish TA indicator(s).

  • ABOS’s TA Score: 6 bullish, 4 bearish.
  • MOR’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than MOR.

Price Growth

ABOS (@Biotechnology) experienced а -1.20% price change this week, while MOR (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +5.11%, and the average quarterly price growth was +88.95%.

Reported Earning Dates

ABOS is expected to report earnings on May 13, 2024.

MOR is expected to report earnings on Apr 29, 2024.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ABOS with price predictions.
OPEN
A.I.dvisor published
a Summary for MOR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MOR($2.74B) has a higher market cap than ABOS($237M). MOR has higher P/E ratio than ABOS: MOR (24.63) vs ABOS (3.40). MOR YTD gains are higher at: 83.182 vs. ABOS (6.771). ABOS has higher annual earnings (EBITDA): -56.71M vs. MOR (-70.53M). MOR has more cash in the bank: 683M vs. ABOS (215M). ABOS has less debt than MOR: ABOS (2K) vs MOR (636M). MOR has higher revenues than ABOS: MOR (238M) vs ABOS (0).
ABOSMORABOS / MOR
Capitalization237M2.74B9%
EBITDA-56.71M-70.53M80%
Gain YTD6.77183.1828%
P/E Ratio3.4024.6314%
Revenue0238M-
Total Cash215M683M31%
Total Debt2K636M0%
FUNDAMENTALS RATINGS
MOR: Fundamental Ratings
MOR
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSMOR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 21 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 8 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
ABOSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MORDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLEIX12.210.10
+0.83%
GS Energy Infrastructure Fd Inv Shares
BRTNX68.330.54
+0.80%
Bretton Fund
RFNEX79.330.46
+0.58%
American Funds Fundamental Invs R4
GSEUX65.20N/A
N/A
Goldman Sachs US Equity Insights R6
CSMZX23.54N/A
N/A
Carillon Scout Mid Cap Y

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with BBIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+9.33%
BBIO - ABOS
50%
Loosely correlated
+3.76%
PEPG - ABOS
37%
Loosely correlated
+6.02%
DNLI - ABOS
36%
Loosely correlated
+4.48%
CPRX - ABOS
36%
Loosely correlated
+3.37%
CTMX - ABOS
35%
Loosely correlated
+4.27%
More